Publications by authors named "B Frandji"
Aim: Height velocity is considered a key auxological tool to monitor growth, but updated height velocity growth charts are lacking. We aimed to derive new French height velocity growth charts by using a big-data approach based on routine measurements.
Methods: We extracted all growth data of children aged 1 month-18 years from the electronic medical records of 42 primary care physicians, between 1 January 1990 and 8 February 2018, throughout the French metropolitan territory.
Article Synopsis
- Respiratory syncytial virus (RSV) is a major cause of lower respiratory infections in children, and a new monoclonal antibody, nirsevimab, was introduced in September 2023 to combat RSV.
- A study was conducted on infants under 12 months old to evaluate the effectiveness of nirsevimab against RSV-bronchiolitis in outpatient settings, involving a comparison between RSV-positive and RSV-negative bronchiolitis patients.
- The findings showed that nirsevimab reduced the risk of RSV-bronchiolitis by 79.7%, indicating its effectiveness in preventing this infection in young children during outpatient care.
Objectives: We evaluated the burden of noninvasive group A Streptococcus (GAS) infections in ambulatory pediatrics before and during the COVID-19 pandemic in France.
Methods: We analyzed data from a national network of ambulatory pediatricians between 2018 and 2022. Clinicians evaluating children ≤15 years old for tonsillopharyngitis, perianal infections, paronychia/blistering dactylitis, and scarlet fever were invited to perform a rapid antigen detection test (RADT) for GAS.
Article Synopsis
- The study examines the impact of non-pharmaceutical interventions (NPIs) during the Covid-19 pandemic on pediatric infectious diseases in France.
- Data from 107 pediatricians showed a significant decrease in recorded infectious diseases in 2020 compared to 2018-2019, with a notable reduction in conditions like scarlet fever and bronchiolitis.
- In 2021, a rebound in certain infections was observed, exceeding pre-pandemic levels, emphasizing the importance of ongoing monitoring of infectious diseases post-NPIs.